ECL · Ecolab Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Fixed currency operating income margin non-GAAP | 26.5% | the second quarter of 2026 filing | — |
| Non-GAAP adjusted fixed currency operating income margin non-GAAP | 18.4% | Second Quarter Ended June 30, 2026 filing | — |
| Ecolab Digital sales | $121M | second quarter 2026 | — |
|
|
|||
| Net Debt/Adjusted EBITDA* non-GAAP | 1.9 | June 30 | — |
| Non-GAAP adjusted diluted EPS non-GAAP | $3.79 | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP adjusted fixed currency operating income non-GAAP | 1.49B | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP adjusted gross margin non-GAAP | 44% | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP adjusted gross profit non-GAAP | 3.73B | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP adjusted net income attributable to Ecolab non-GAAP | 1.07B | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP adjusted operating income non-GAAP | 1.49B | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP adjusted operating income margin non-GAAP | 17.6% | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP adjusted tax rate non-GAAP | 21% | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP fixed currency sales non-GAAP | 8.46B | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP organic gross margin non-GAAP | 44.5% | Six Months Ended June 30 | — |
| Non-GAAP organic operating income non-GAAP | 1.47B | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP organic operating income margin non-GAAP | 17.8% | Six Months Ended June 30 | — |
|
|
|||
| Non-GAAP organic sales non-GAAP | 8.24B | Six Months Ended June 30 | — |
|
|
|||
| Organic OI margin non-GAAP | 18.8% | Second Quarter 2026 | — |
|
|
|||
| Organic operating income margin non-GAAP | 18.8% | Second Quarter Ended June 30 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | $4.04B | trailing twelve months ended March 31, 2026 | — |
| Adjusted gross margin non-GAAP | 43.8% | 1Q 2026 | — |
|
|
|||
| EBITDA | $3.85B | trailing twelve months ended March 31, 2026 | +2.4% |
|
|
|||
| Organic operating income non-GAAP | $664.9M | 1Q 2026 | — |
|
|
|||
| Organic sales growth non-GAAP | 4% | 1Q 2026 | — |
| Adj. fixed currency operating income non-GAAP | $742.6M | 4Q 2025 | — |
| Adj. fixed currency operating income margin non-GAAP | 18.5% | 4Q 2025 | — |
| Non-GAAP adjusted fixed currency sales non-GAAP | $15.56B | Twelve Months Ended December 31, 2025 | — |
| Non-GAAP adjusted net sales non-GAAP | $16.08B | Twelve Months Ended December 31, 2025 | — |
| Organic operating income - Global Institutional & Specialty non-GAAP | $335M | 4Q 2025 | — |
| Organic operating income - Global Life Sciences non-GAAP | $32.6M | 4Q 2025 | — |
| Organic operating income - Global Pest Elimination non-GAAP | $62.5M | 4Q 2025 | — |
| Organic operating income - Global Water non-GAAP | $360.3M | 4Q 2025 | — |
| Organic operating income margin - Global Institutional & Specialty non-GAAP | 22.4% | 4Q 2025 | — |
| Organic operating income margin - Global Life Sciences non-GAAP | 17% | 4Q 2025 | — |
| Organic operating income margin - Global Pest Elimination non-GAAP | 20.4% | 4Q 2025 | — |
| Organic operating income margin - Global Water non-GAAP | 18% | 4Q 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ECL
this stock
Ecolab Inc.
|
$80.38B | +9.2% | +2.2% | 38.5 | 1.2% |
|
LIN
Linde PLC
|
$225.65B | +14.8% | +3.0% | 31.6 | 1.1% |
|
AIQUF
L Air Liquide SA /Fi
|
$126.15B | +5.6% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.55B | +6.4% | +2.1% | 31.8 | 2.6% |
|
APD
Air Products & Chemicals, Inc.
|
$68.61B | +24.7% | -0.5% | — | 1.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ECL | +1.8% | +3.3% | +1.7% | +3.3% | +9.2% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +1.4% | +0.3% | -11.7% | +0.3% | -3.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.